Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Accumulated Depreciation (2023 - 2025)

Metagenomi (MGX) has disclosed Accumulated Depreciation for 3 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation rose 41.64% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.0 million through Dec 2025, up 41.64% year-over-year, with the annual reading at $16.0 million for FY2025, 41.64% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $16.0 million at Metagenomi, up from $11.3 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $16.0 million in Q4 2025, with the low at $6.4 million in Q4 2023.
  • Average Accumulated Depreciation over 3 years is $11.2 million, with a median of $11.3 million recorded in 2024.
  • The sharpest move saw Accumulated Depreciation skyrocketed 75.15% in 2024, then soared 41.64% in 2025.
  • Over 3 years, Accumulated Depreciation stood at $6.4 million in 2023, then surged by 75.15% to $11.3 million in 2024, then skyrocketed by 41.64% to $16.0 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $16.0 million, $11.3 million, and $6.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.